A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in Belgium-Reference-Cited by-同舟云学术

A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in Belgium

Published:2016-08-23 Issue:1 Volume:54 Page:383-395
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Somers Charisse¹,Struyfs Hanne¹,Goossens Joery¹,Niemantsverdriet Ellis¹,Luyckx Jill¹,De Roeck Naomi¹,De Roeck Ellen¹,De Vil Bart²,Cras Patrick²³,Martin Jean-Jacques⁴,De Deyn Peter-Paul¹⁵⁴,Bjerke Maria¹,Engelborghs Sebastiaan¹⁵

Affiliation:

1. Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

2. Laboratory of Neurobiology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

3. Department of Neurology, Antwerp University Hospital, Antwerp, Belgium

4. Biobank, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

5. Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference52 articles.

1. Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: A follow-up study;Hansson;Lancet Neurol,2006

2. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia;Engelborghs;Neurobiol Aging,2008

3. Amyloid-(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease;Mulder;Clin Chem,2010